Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ospemifene (FC-1271a) is a new selective non-hormonal estrogen receptor modulator (SERM) that is used for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. FDA approved on February 26, 2013.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 46.00 | |
25 mg | In stock | $ 61.00 | |
100 mg | In stock | $ 90.00 | |
200 mg | In stock | $ 135.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Ospemifene (FC-1271a) is a new selective non-hormonal estrogen receptor modulator (SERM) that is used for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. FDA approved on February 26, 2013. |
Targets&IC50 | ERβ:1633nM, ERα:827nM |
Synonyms | FC-1271a |
Molecular Weight | 378.89 |
Formula | C24H23ClO2 |
CAS No. | 128607-22-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 70 mg/mL (184.8 mM)
Ethanol: 66 mg/mL (174.2 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ospemifene 128607-22-7 Endocrinology/Hormones Estrogen Receptor/ERR Estrogen/progestogen Receptor FC-1271a inhibit Inhibitor inhibitor